论文部分内容阅读
目的观察艾迪注射液联合化疗对晚期非小细胞肺癌的近期疗效。方法选取我院自2006年1月～2009年12月收治的64例晚期非小细胞肺癌患者随机分为观察组(联合治疗组)和对照组(化疗组)各32例,观察比较两组患者的治疗效果。结果两组疗效和不良反应比较均有统计学意义。结论艾迪注射液联合化疗可以提高晚期非小细胞肺癌的临床缓解率,并可降低治疗过程中的不良反应发生率。
Objective To observe the short-term curative effect of Aidi injection combined with chemotherapy on advanced non-small cell lung cancer. Methods Sixty-four patients with advanced non-small cell lung cancer who were treated in our hospital from January 2006 to December 2009 were randomly divided into observation group (combination group) and control group (chemotherapy group), 32 cases in each group. Therapeutic effect. Results The curative effect and adverse reaction of two groups were statistically significant. Conclusion Aidi injection combined with chemotherapy can improve the clinical remission rate of advanced non-small cell lung cancer and reduce the incidence of adverse reactions in the course of treatment.